NUP62 and lip and oral cavity carcinoma: We also analyzed the co-expression of Nup62 and Nup88 in oral cancers in a collection of available datasets at MiPanda (25), and found that Nup62 and Nup88 transcript levels were significantly higher in primary tumors when compared to normal samples (Figure S1E).